Abeona Therapeutics (ABEO) Invested Capital: 2011-2025
Historic Invested Capital for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $180.1 million.
- Abeona Therapeutics' Invested Capital rose 258.69% to $180.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.1 million, marking a year-over-year increase of 258.69%. This contributed to the annual value of $50.0 million for FY2024, which is 236.96% up from last year.
- Abeona Therapeutics' Invested Capital amounted to $180.1 million in Q3 2025, which was up 6.50% from $169.1 million recorded in Q2 2025.
- Abeona Therapeutics' 5-year Invested Capital high stood at $180.1 million for Q3 2025, and its period low was -$8.9 million during Q1 2024.
- In the last 3 years, Abeona Therapeutics' Invested Capital had a median value of $49.5 million in 2025 and averaged $57.3 million.
- Examining YoY changes over the last 5 years, Abeona Therapeutics' Invested Capital showed a top increase of 707.52% in 2024 and a maximum decrease of 147.39% in 2024.
- Quarterly analysis of 5 years shows Abeona Therapeutics' Invested Capital stood at $47.0 million in 2021, then slumped by 43.02% to $26.8 million in 2022, then plummeted by 44.60% to $14.8 million in 2023, then surged by 236.96% to $50.0 million in 2024, then soared by 258.69% to $180.1 million in 2025.
- Its Invested Capital was $180.1 million in Q3 2025, compared to $169.1 million in Q2 2025 and $49.5 million in Q1 2025.